E-LIB Suche - Ergebnisse für: Van der Graaf, Y.

1

Low-grade inflammation as a risk factor for cardiovascular ..:

Sharif, Shahnam ; Van der Graaf, Y. ; Cramer, M. J....
Cardiovascular Diabetology. 20 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

2

Predicting 10-year risk of recurrent cardiovascular events ..:

Klooster, C.C. van 't ; Bhatt, D.L. ; Steg, P.G....
International Journal of Cardiology. 325 (2021) - p. 140-148 , 2021

Link: https://doi.org/10.1016/..

3

The relation between healthy lifestyle changes and decrease..:

van 't Klooster, C.C. ; van der Graaf, Y. ; Ridker, P.M....
Atherosclerosis. 301 (2020) - p. 37-43 , 2020

Link: https://doi.org/10.1016/..

4

Prediction of 10-year and lifetime risk of cancer in indivi..:

Van 't Klooster, C.C ; Ridker, P.M ; Cook, N.R...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

5

Association of hippocampal calcification and cardiovascular..:

van der Knaap, Marije J.A. ; Peters, Melissa E.M. ; Lucci, Carlo...
Atherosclerosis Supplements. 39 (2019) - p. 100005 , 2019

Link: https://doi.org/10.1016/..

6

2180Estimating individual lifetime benefit and bleeding ris..:

De Vries, T I ; Eikelboom, J W ; Bosch, J...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

7

P646Effects of personalized therapy-effect predictions on s..:

Jaspers, N E M ; Visseren, F L J ; Van Der Graaf, Y...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

8

Limited benefit of haemoglobin glycation index as risk fact..:

Østergaard, H.B. ; Mandrup-Poulsen, T. ; Berkelmans, G.F.N....
Diabetes & Metabolism. 45 (2019) 3 - p. 254-260 , 2019

Link: https://doi.org/10.1016/..

9

P4990Heterogeneity of treatment effects from an intensive l..:

De Vries, T I ; Dorresteijn, J A N ; Van Der Graaf, Y..
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

10

2153The relation between systemic inflammation and incident..:

Van 'T Klooster, C C ; Ridker, P M ; Hjortnaes, J...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

11

P3411Prevalence and risk factors of multifocal cardiovascul..:

Van 'T Klooster, C C ; Nathoe, H M ; Leiner, T...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

12

1412Risk of urinary sodium excretion and sodium-to-potassiu..:

Vendeville, A C J ; Visseren, F L J ; Blankestijn, P J...
European Heart Journal. 39 (2018) suppl_1 - p. , 2018

Link: https://doi.org/10.1093/..

13

Thyroid-stimulating hormone levels in the normal range and ..:

on behalf of the SMART study group ; de Vries, T. I. ; Kappelle, L. J....
Acta Diabetologica. 56 (2018) 4 - p. 431-440 , 2018

Link: https://doi.org/10.1007/..

14

P5084Added predictive value of follow-up blood-pressure mea..:

Jaspers, N E M ; Visseren, F L J ; Berkelmans, G F N...
European Heart Journal. 39 (2018) suppl_1 - p. , 2018

Link: https://doi.org/10.1093/..

15

5970Who to test for primary aldosteronism: development of a..:

Van Kleef, M E A M ; Visseren, F L J ; Deinum, J..
European Heart Journal. 39 (2018) suppl_1 - p. , 2018

Link: https://doi.org/10.1093/..